维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

15篇 您的检索式：作者名="Corbacioglu S"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Acute myeloid leukemia(AML)with 9q aberrations occurring within a non-complex karyotype is highly associated with CEBPA and NPM1 mutations–a joint analysis of the German-Austrian AML Study Group(AMLSG)and Cancer and Leukemia Group B(CALGB)显示文摘	Corbacioglu A Frhling S Paschka P	2007	Blood2007，110，1：	1
	2	Gemtuzumab ozogamicin: first clinical experiences in children with relapsed/refractory acute myeloid leukemia treated on compassionate-use basis显示文摘	Zwaan C M Reinhardt D Corbacioglu S	2003	Blood2003，101，10：	1
	3	Defibrotide in the treatment of children with veno-occlusive disease(VOD): retrospective multicentre study demonstrates therapeutic efficacy upon early intervention显示文摘	CORBACIOGLU S GREIL J PETERS C	2004	Bone Marrow Transplant2004，33，：	1
	4	Effects of bone marrow fibroblasts on the proliferation and differentiation of myeloid leukemic cell lines 显示文摘	Stolze B Emmendorffer A Corbacioglu S	1995	Exp Hematol1995，23，13：	1
	5	Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial 显示文摘	Corbacioglu S Cesaro S Faraci M	2012	Lancet2012，379，9823：	1
	6	Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation:an open-label,Phase 3,randomised controlled trial显示文摘	CORBACIOGLU S CESARO S FARACI M	2012	Lancet2012，379，9823：	1
	7	Defibrotide for the treatment of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation显示文摘	CORBACIOGLU S KERNAN N LEHMANN L	2012	Expert Rev Hematol2012，5，3：	1
	8	Clinical implications of c-Kit mutations in acute myelogenous leukemia显示文摘	Malaise M Steinbach D Corbacioglu S	2009	Curr Hematol Malig Rep2009，4，2：	1
	9	Gemtuzumab ozogamicin:first clinical experiences in children with relapsed/refractory acute myeloid leukemia treated on compassionate-use basis显示文摘	Zwaan C M Reinhardt D Corbacioglu S	2003	Blood2003，101，10：	1
	10	Organizational Learning and Self-adaptation in Dynamic Disaster Environments 显示文摘	CORBACIOGLU S KAPUCU N	2006	Disasters2006，30，2：	1
	11	Defibrotide for prophy-laxis of hepatic veno-occlusive disease in paediatric haemopoieticstem-cell transplantation : an open-label,phase 3,randomisedcontrolled trial显示文摘	Corbacioglu S Cesaro S Faraci M	2012	Lancet2012，379，9823：	1
	12	Defibroti- de for prophylaxis of hepatic veno -occlusive disease in pae- diatric haemopoietic stem -cell transplantation; an open -la- bel, phase 3, randomised controlled trial显示文摘	CORBACIOGLU S CESARO S FARACI M	2012	Lancet2012，379，9823：	1
	13	Role of information in collective action in dynamic disaster environment显示文摘	Celik S Corbacioglu S	2010	Disasters2010，34，1：	1
	14	Clinical implications of c-Kit mutations in acute myelogenous leukemia显示文摘	Malaise M Steinbach D Corbacioglu S	2009	Curr Hematol Malig Rep2009，4，2：	1
	15	Clinical implicatiom of c-Kit mutations in acute myelogenous leukemia 显示文摘	Malaise M Steinbach D Corbacioglu S	2009	Curt Hematol Malig Rep2009，4，2：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费